Effect of antiviral therapy on 3-year recurrence and prognosis of hepatocellular carcinoma after curative radiofrequency ablation
Among patients with hepatitis B cirrhosis-related HCC, TDF and TAF are associated with lower 2-year and 3-year HCC recurrence rates after curative RFA treatment compared with ETV. However, there were no significant differences in 3-year mortality rates between the ETV, TDF, and TAF groups.
Authors
- Baiguo Xu (ORCID: https://orcid.org/0000-0002-0269-5155)
- Feng-Hui Li
- Xu Zhang (ORCID: https://orcid.org/0000-0002-6908-6768)
- Xue Zhang (ORCID: https://orcid.org/0000-0003-3655-8308)
- Fang Liu (ORCID: https://orcid.org/0000-0002-2073-1682)
- Jing Liang (ORCID: https://orcid.org/0000-0001-5114-9030)
- Huiling Xiang (ORCID: https://orcid.org/0000-0001-5734-4080)
Institutions
- Tianjin Third Central Hospital (CN)
- Tianjin Medical University (CN)
Publication Details
- Journal
- World Journal of Gastrointestinal Oncology
- Published
- 2025-11-12
- DOI
- https://doi.org/10.4251/wjgo.v17.i11.112689
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00